Workflow
三特索道(002159) - 2024 Q2 - 季度业绩预告
SanteSante(SZ:002159)2024-07-12 10:09

Financial Performance - The estimated net profit for the first half of 2024 is projected to be between 60 million and 90 million CNY, representing a year-on-year increase of 18% to 77% compared to 50.89 million CNY in the same period last year[3]. - The estimated net profit after deducting non-recurring losses is expected to be between 56 million and 84 million CNY, indicating a year-on-year decrease of 10% to an increase of 35% compared to 62.26 million CNY last year[3]. - The basic earnings per share are projected to be between 0.34 CNY and 0.51 CNY, compared to 0.29 CNY in the same period last year[3]. - The increase in net profit is attributed to improved asset-liability structure and cost management, despite a slight decline in operating revenue[6]. Non-Recurring Losses - There were no non-recurring losses in the current period, unlike the previous year which included a provision for housing demolition compensation of 13.71 million CNY[6]. - The previous year also saw a provision for impairment of long-term equity investments in associates amounting to 13.37 million CNY, which is not present in the current period[6]. Financial Reporting - The financial data in this earnings forecast is a preliminary estimate and has not been audited by an accounting firm[4]. - The earnings forecast period is from January 1, 2024, to June 30, 2024[3]. - The official financial data will be disclosed in the company's 2024 semi-annual report[7]. Investor Advisory - The company advises investors to make cautious decisions and be aware of investment risks[8].